Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
Top Cited Papers
Open Access
- 13 August 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (8) , e2942
- https://doi.org/10.1371/journal.pone.0002942
Abstract
Osteocytes, former osteoblasts buried within bone, are thought to orchestrate skeletal adaptation to mechanical stimuli. However, it remains unknown whether hormones control skeletal homeostasis through actions on osteocytes. Parathyroid hormone (PTH) stimulates bone remodeling and may cause bone loss or bone gain depending on the balance between bone resorption and formation. Herein, we demonstrate that transgenic mice expressing a constitutively active PTH receptor exclusively in osteocytes exhibit increased bone mass and bone remodeling, as well as reduced expression of the osteocyte-derived Wnt antagonist sclerostin, increased Wnt signaling, increased osteoclast and osteoblast number, and decreased osteoblast apoptosis. Deletion of the Wnt co-receptor LDL related receptor 5 (LRP5) attenuates the high bone mass phenotype but not the increase in bone remodeling induced by the transgene. These findings demonstrate that PTH receptor signaling in osteocytes increases bone mass and the rate of bone remodeling through LRP5-dependent and -independent mechanisms, respectively.Keywords
This publication has 79 references indexed in Scilit:
- Targeted Deletion of a Distant Transcriptional Enhancer of the Receptor Activator of Nuclear Factor-κB Ligand Gene Reduces Bone Remodeling and Increases Bone MassEndocrinology, 2007
- Molecular and cellular mechanisms of the anabolic effect of intermittent PTHBone, 2007
- Serial analysis of chromatin occupancy identifies β-catenin target genes in colorectal carcinoma cellsProceedings of the National Academy of Sciences, 2007
- Induction of Osteoblast Differentiation by Selective Activation of Kinase-Mediated Actions of the Estrogen ReceptorMolecular and Cellular Biology, 2007
- Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolismNature Genetics, 2006
- Parathyroid Hormone Controls Receptor Activator of NF-κB Ligand Gene Expression via a Distant Transcriptional EnhancerMolecular and Cellular Biology, 2006
- Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgeneBone, 2004
- In vivo administration of 1,25‐dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTHJournal of Cellular Biochemistry, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Identification of apoptotic changes in osteocytes in normal and pathological human boneBone, 1997